AI MARKET SCANNING

Aquestive Therapeutics, Inc.

AVG HISTORICAL GAP +0.94%
MAX GAP RECORD +4.21%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $AQST
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Oct 15, 2026 Earnings Release 2026-10-15 (AFTER CLOSE (17:00))
+0.95%
Jul 13, 2026 Earnings Release 2026-07-13 (BEFORE OPEN)
+0.00%
Apr 23, 2026 Earnings Release 2026-04-23 (BEFORE OPEN)
+0.00%
Feb 12, 2026 Earnings Release 2026-02-12 (BEFORE OPEN)
+1.79%
Oct 16, 2025 Earnings Release 2025-10-16 (BEFORE OPEN)
-2.24%
Jul 15, 2025 Earnings Release 2025-07-15 (BEFORE OPEN)
-2.80%
Apr 23, 2025 Earnings Release 2025-04-23 (BEFORE OPEN)
+4.21%
Feb 13, 2025 Earnings Release 2025-02-13 (BEFORE OPEN)
+3.74%

VOLATILITY & GAP BIAS

AVG GAP MOVE 2.6%
Bullish Gaps (3)
Bearish Gaps (2)
Neutral / Flat (1)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $AQST

EXECUTIONS2 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-10-30 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 2890m +9.17%
••••-••-•• 🔒 LOCKED ••• x• $•••.•• → $•••.•• ••m +••.••%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; EMYLIF, an oral film formulation of…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗